S&P 500
(-0.27%) 4 288.05 points
Dow J
(-0.47%) 33 508 points
Nasdaq
(0.14%) 13 219 points
Oil
(0.41%) $91.16
Gas
(-1.02%) $2.90
Gold
(-0.34%) $1 859.80
Silver
(-1.76%) $22.06
Platinum
(1.44%) 919.90
USD/EUR
(0.06%) 0.946
USD/NOK
(0.12%) 10.71
USD/GBP
(0.08%) 0.820
USD/RUB
(0.00%) 96.48
Picture of a house with link to the home page

Realtime updates for Vir Biotechnology Inc [VIR]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
BUY
48.98%
return -17.83%
SELL
32.00%
return 89.60%
Last Updated29 Sep 2023 @ 16:00
Share On:
50% discount on Stockinvest.us - Use code: Podcast

1.74% $ 9.37

BUY 3595 min ago

@ $9.32

Issued: 29 Sep 2023 @ 11:38

Return: 0.54%

Previous signal: Sep 26 - 15:47

Previous signal: Sell

Return: 0.11 %

Live Chart Being Loaded With Signals

Profile picture for Vir Biotechnology Inc

Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; and VIR-1111 for the prevention of human immunodeficiency virus...

Stats
Today's Volume 1.19M
Average Volume 1.57M
Market Cap 1.26B
EPS $-1.450
Earnings date 2023-08-03
Next earnings date 2023-11-01 ( $-1.210)
P/E -4.81
ATR14 $0.198 (2.12%)

Volume Correlation

Long: -0.58 (weak negative)
Short: -0.82 (strong negative)
Signal:(52) Neutral

Vir Biotechnology Inc Correlation

10 Most Positive Correlations
MMAC0.954
BOCH0.943
NETE0.913
SHSP0.859
AMRB0.843
RAVN0.843
SILC0.824
DSPG0.802
10 Most Negative Correlations
PAIC-0.934
RMRM-0.927
SVOK-0.922
SVAC-0.888
ISNS-0.888
APOP-0.887
FEYE-0.874
GAINL-0.872
SPRT-0.837
TDAC-0.828

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Vir Biotechnology Inc Correlation - Currency/Commodity

The country flag -0.03
( neutral )
The country flag 0.35
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.49
( neutral )

Vir Biotechnology Inc Financials

Annual 2022
Revenue: $1.58B
Gross Profit: $1.43B (90.74 %)
EPS: $3.89
Q2 2023
Revenue: $-12.72M
Gross Profit: $-12.74M (100.17 %)
EPS: $-1.450
Q1 2023
Revenue: $46.71M
Gross Profit: $44.81M (95.92 %)
EPS: $-1.060
Q4 2022
Revenue: $21.79M
Gross Profit: $15.79M (72.48 %)
EPS: $-0.760

Vir Biotechnology Inc

Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; and VIR-1111 for the prevention of human immunodeficiency virus. The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited and Brii Biosciences Offshore Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with The Rockefeller University and MedImmune, Inc.; collaboration with WuXi Biologics and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with GlaxoSmithKline Biologicals SA. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. for the manufacture of SARS-COV-2 antibodies; and clinical collaboration with Gilead Sciences, Inc. for chronic hepatitis B virus. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

Estimated
 VIR Next Dividend
 (Unknown) $0 Probabilty 0 %
Quarter Ratio
 VIR 0.00 0.00
Pay Frequency
 VIR Insufficient data to determine frequency 0
Yearly Payout
 VIR

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

DISCLAIMER:

"Getagraph.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "Getagraph.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.
Total Execution Time: 1.8892941474915 seconds
Number of API calls: 1
Number of DB calls: 9